nucleic
acid
amplif
test
naat
becom
indispens
tool
biolog
medicin
exampl
infecti
diseas
diagnost
naat
gener
faster
sensit
specif
current
gold
standard
culturebas
techniqu
fact
number
dna
rnabas
diagnost
recommend
us
food
drug
administr
fda
infecti
diseas
human
immunodefici
viru
hiv
bring
naat
point
care
poc
particularli
resourcepoor
set
envis
revolution
healthcar
unfortun
mani
naat
requir
access
expens
special
equip
degre
expertis
highli
unlik
found
decentr
laboratori
addit
challeng
test
typic
requir
extract
step
isol
dna
rna
blood
urin
sputum
purif
step
elimin
contamin
sampl
matrix
confound
actual
detect
procedur
figur
procedur
necessit
expens
instrument
add
sever
hour
sampletoansw
result
restrict
use
naat
within
central
laboratori
mani
group
attempt
develop
portabl
integr
microfluidicsbas
platform
increas
function
diagnost
sens
analysi
even
commerci
eg
biomerieux
nuclisen
easyq
test
twistdx
twistamp
kit
enigma
diagnost
minilab
platform
present
breakthrough
technolog
rapid
costeffect
userfriendli
diagnost
remain
seen
whether
system
simpl
errorfre
enough
develop
develop
set
demonstr
feasibl
implement
exist
nucleic
acid
amplif
method
poc
use
altern
approach
timeconsum
cumbersom
sampl
prepar
perform
naat
directli
complex
sampl
figur
advantag
tradit
amplif
technolog
pcr
realtim
spectroscop
mass
spectrometri
detect
result
highli
specif
quantit
howev
sens
platform
expens
requir
prior
extract
genet
materi
sampl
direct
naat
advantag
complic
costli
laboratori
apparatus
avail
reduc
time
labor
technic
constraint
molecular
test
also
bring
addit
benefit
standard
result
inde
grow
number
group
develop
direct
naat
notabl
aler
influenza
b
assay
becam
first
fda
clinic
laboratori
improv
amend
clia
waiv
nucleic
acidbas
test
januari
aler
system
requir
frontend
nucleic
acid
extract
use
outsid
tradit
laboratori
site
develop
cliawaiv
statu
provid
strong
support
develop
direct
assay
minim
even
bypass
sampl
prepar
thu
motiv
present
current
state
direct
assay
platform
achiev
nucleic
acid
detect
analysi
clinicallyrelev
complex
sampl
either
minim
even
sampl
prepar
procedur
survey
literatur
came
across
signific
number
work
report
naat
bodili
sampl
eg
bloodbas
liquid
oral
sampl
swab
without
complex
step
gener
involv
sampl
prepar
meant
discard
work
depend
sophist
instrument
oper
labor
time
costintens
enzymat
proteinas
chemic
acid
deterg
physic
temperatur
shock
mechan
disrupt
treatment
describ
exampl
wherebi
data
visual
use
reveal
connect
robust
sensit
efficaci
technolog
develop
direct
dna
rnabas
test
hope
review
technolog
present
promis
earli
find
informationrich
access
fashion
help
acceler
develop
approach
make
poc
nucleic
acid
test
rapid
accur
simpl
afford
search
googl
scholar
combin
search
term
follow
formula
combin
descriptor
eg
pointofcar
amplif
technolog
eg
lamp
loopmedi
isotherm
amplif
sampl
matrix
eg
blood
refer
previous
publish
review
well
includ
origin
studi
check
possibl
candid
articl
articl
initi
screen
titl
secondli
abstract
articl
reli
microfluid
platform
commerci
extract
devic
exclud
public
requir
complex
preprocess
enzymat
treatment
chemic
purif
select
studi
includ
involv
direct
amplif
detect
genet
materi
one
six
repres
sampl
type
blood
dri
blood
spot
serum
plasma
saliva
sputum
swab
urin
stool
full
text
appropri
articl
read
extract
necessari
inform
publish
work
survey
extract
record
data
correspond
test
perform
mani
paramet
ignor
consid
naat
accuraci
specif
userfriendli
train
requir
provid
extens
examin
nucleic
acid
templat
specif
includ
singl
multiplex
reaction
amplif
methodolog
enzym
oper
temperatur
amplif
technolog
userfriendli
storag
consider
pretreat
requir
physic
involv
supplementari
tabl
addit
classifi
assay
feasibl
complet
without
extens
train
highend
instrument
direct
wherea
greater
labor
equip
demand
eg
freezer
highspe
centrifug
incub
multipl
hour
deem
semidirect
specif
semidirect
assay
follow
except
simpl
laboratori
setup
altern
two
incub
temperatur
room
temperatur
reli
enzymat
activ
requir
brief
lowspe
g
centrifug
method
categor
semidirect
face
hurdl
implement
onsit
servic
patient
care
test
offer
way
deliv
action
result
link
diagnosi
treatment
appropri
convers
requir
highli
train
staff
sophist
tool
easytous
method
semidirect
procedur
meet
requir
poc
diagnost
devic
found
certain
paramet
could
distil
numer
data
yield
particularli
use
insight
examin
differ
test
devis
three
major
criteria
indic
platform
robust
sensit
clinic
efficaci
toler
sampl
assay
abl
detect
target
high
concentr
background
contamin
note
although
sampl
dilut
sometim
provid
conveni
way
permit
amplif
inevit
reduc
limit
detect
lod
naat
analyz
fraction
sampl
volum
sampl
dilut
therefor
increas
likelihood
fals
neg
result
especi
sampl
alreadi
low
target
forego
sampl
prepar
one
gener
sacrific
opportun
concentr
bulk
sampl
reduc
limit
detect
make
sensit
import
considerationclin
assay
valid
clinic
sampl
final
sought
devis
visual
strategi
would
clearli
quickli
commun
import
criteria
compar
wide
rang
assay
discov
trend
data
reveal
pattern
singl
glanc
specif
essenti
inform
review
public
present
quantit
singl
plot
relev
valu
standard
commun
term
visual
attribut
posit
size
shape
color
found
particularli
use
visual
data
bubbl
plot
bubbl
plot
numer
valu
three
paramet
simultan
visual
via
two
axe
size
circular
marker
differ
categori
also
group
accord
color
marker
case
readili
display
essenti
inform
eg
sampl
toler
lod
instanc
clinic
test
relat
procedur
discern
enhanc
test
perform
pcr
commonli
report
method
amplif
increas
number
isotherm
amplif
technolog
truli
use
poc
singl
reaction
temperatur
enabl
use
less
costli
complic
instrument
thermal
cycl
test
loopmedi
isotherm
amplif
lamp
one
wide
research
develop
character
method
amplif
employ
stranddisplac
polymeras
two
three
pair
primer
one
sacrif
linear
templat
one
two
other
prime
dna
synthesi
produc
concaten
cauliflowerlik
product
pcr
lamp
modifi
target
rna
reversetranscript
rt
lamp
lamp
compar
pcr
way
well
includ
applic
bacteri
viral
fungal
parasit
assay
specif
sensit
equival
pcr
robust
lamp
certain
prepar
serum
swab
blood
shown
toler
inhibitor
pcr
nucleic
acid
sequencebas
amplif
nasba
method
uniqu
abil
amplifi
singlestrand
rna
directli
desir
target
rna
virus
transcriptom
analysi
continu
homogen
isotherm
process
reli
rna
polymeras
rnase
revers
transcriptas
first
revers
transcriptas
creat
doubl
strand
rna
dna
hybrid
rna
templat
next
origin
rna
destroy
dna
duplex
synthes
polymeras
transcrib
rna
dna
new
rna
molecul
repeat
cycl
exponenti
amplif
nasba
appli
widerang
set
research
problem
includ
hiv
diagnosi
aid
epidem
autom
realtim
clinic
test
blood
modern
nuclisen
biomerieux
inc
durham
nc
usa
urin
aptima
assay
holog
san
diego
ca
usa
nasba
also
use
outsid
commerci
sector
system
monitor
virus
serum
strand
displac
amplif
sda
techniqu
base
upon
abil
restrict
enzym
dna
polymeras
primer
contain
recognit
sequenc
restrict
enzym
bind
complementari
singl
strand
dna
target
extens
polymeras
restrict
enzym
nick
unmodifi
strand
doublestrand
hemiphosphorothio
recognit
site
dna
polymeras
extend
end
nick
displac
downstream
strand
end
result
exponenti
target
amplif
displac
strand
serv
target
new
reaction
sda
complex
suffer
sensit
issu
presenc
background
dna
best
way
overcom
offtarget
amplif
henc
reduc
falseposit
use
simpl
pretreat
procedur
like
develop
detect
bdprobetec
becton
dickinson
microbiolog
system
spark
md
usa
inhous
system
urin
recombinas
polymeras
amplif
rpa
avoid
thermal
cycl
use
three
core
protein
oper
optim
first
protein
recombinas
bind
primer
recombin
duplex
target
strand
displac
second
singlestrand
dna
bind
protein
attach
displac
strand
stranddisplac
polymeras
copi
dna
primer
onward
exponenti
amplif
one
requir
rpa
technolog
sequencespecif
detect
avoid
problem
primer
artifact
add
background
fluoresc
nonspecif
intercal
dye
specif
readout
rapid
min
result
two
main
featur
rpa
provid
altern
timeconsum
process
cultur
bacteri
genotyp
test
pathogen
strand
invas
base
amplif
siba
anoth
amplif
process
reli
recombinas
activ
siba
separ
recombinas
substrat
insert
two
primerbind
site
duplex
peripher
insert
site
separ
enabl
primer
bind
dna
polymeras
extend
templat
bound
primer
use
invad
substrat
one
neither
consum
includ
extens
dna
advantag
abolish
primer
artifact
siba
therefor
use
reliabl
detect
low
copi
number
isotherm
method
gener
nonspecif
amplif
product
absenc
target
dna
go
specif
siba
enabl
multiplex
detect
templat
differ
littl
two
base
multipl
displac
amplif
mda
techniqu
exploit
strand
displac
proofread
polymeras
activ
bacteriophag
dna
polymeras
highli
process
polymeras
use
random
primer
amplifi
entir
genom
mda
therefor
wellsuit
whole
genom
amplif
crude
biolog
sampl
follow
singl
nucleotid
polymorph
snp
test
genotyp
concept
hybrid
chain
reaction
hcr
enzymefre
roomtemperatur
dna
trigger
initi
amplif
initi
interact
two
stabl
dna
hairpin
creat
nick
doubl
helic
amplif
initi
event
continu
hairpin
deplet
hcr
use
assay
detect
short
dna
human
immunodefici
viru
type
serum
timeseri
plot
offer
effect
mean
show
grow
preval
direct
naat
specif
within
sampl
type
plot
number
clinic
sampl
analyz
direct
naat
figur
also
divid
data
two
cohort
base
whether
sampl
subject
pcr
figur
black
isotherm
amplif
techniqu
figur
red
expect
saw
overal
rise
number
clinic
sampl
analyz
via
naat
minim
sampl
prepar
analyz
period
across
six
sampl
type
observ
sharp
spike
indic
studi
high
number
clinic
sampl
base
sampl
type
swab
sampl
analyz
urin
stool
sampl
least
analyz
within
sampl
type
initi
lag
saw
notabl
rise
use
isotherm
amplif
techniqu
first
becam
appar
earli
sever
year
advent
lamp
twelv
year
introduct
nasba
pcrbase
system
emerg
within
five
year
techniqu
incept
pcr
larg
continu
domin
realm
nucleic
acid
test
one
notabl
except
seen
timecours
blood
test
isotherm
techniqu
surpass
pcr
rtpcr
term
number
assay
perform
whole
blood
sampl
blood
contain
circul
nucleic
acid
cell
differ
protein
offer
abund
biomark
diseas
detect
molecular
diagnost
blood
use
detect
specif
dna
rna
sequenc
rang
bacteri
toxic
viral
infecti
agent
platform
hepat
human
immunodefici
viru
staphylococcu
aureu
plasmodium
speci
mostus
system
enabl
rapid
diagnost
whole
blood
bloodbas
test
gener
demand
sophist
detect
instrument
extens
prepar
recov
inhibitorfre
highpur
dna
inhibitori
blood
compon
known
heme
compound
anticoagul
immunoglobulin
g
igg
interfer
amplif
reaction
inhibit
dna
polymeras
activ
chelat
necessari
cofactor
although
wide
rang
bloodborn
virus
bacteria
parasit
principl
detect
nucleic
acid
test
extract
purificationfre
mean
detect
pathogen
current
commerci
avail
visual
gener
trend
direct
semidirect
nucleic
acid
test
blood
function
lod
figur
vv
blood
toler
reaction
plot
lod
g
templat
number
clinic
sampl
encod
area
bubbl
also
assign
color
indic
type
amplif
technolog
evid
mani
studi
achiev
high
sensit
detect
target
low
concentr
blood
show
nucleic
acid
test
great
potenti
bloodbas
test
poc
situat
collect
volum
small
eg
finger
prick
parasit
load
may
low
exampl
literatur
demonstr
patient
sampl
consid
separ
plot
repres
xs
rather
bubbl
marker
purport
low
lod
reach
fg
level
tabl
remain
seen
whether
test
perform
extrem
sensit
clinic
context
assess
pcr
isothermalbas
data
could
obtain
insight
optim
techniqu
better
toler
blood
sampl
matrix
sever
semidirect
work
pcr
employ
blood
reaction
heatcold
shock
noteworthi
truli
direct
exampl
reli
specif
efficaci
phusion
polymeras
new
england
biolab
ipswich
usa
perform
pcr
blood
pcr
typic
employ
taq
polymeras
thermu
aquaticu
chemic
addit
whether
commerciallyavail
cocktail
inhous
buffer
allow
taq
famili
polymeras
amplifi
dna
whole
blood
pcr
likewis
optim
use
unconvent
polymeras
physic
heat
step
reduc
inhibitori
effect
blood
compon
referenc
work
offer
expedit
method
obtain
amplifi
templat
similar
sensit
chemicalbas
extract
kit
though
sever
author
includ
use
centrifug
extract
process
semidirect
method
templat
prepar
could
like
complet
reli
care
pipettebas
transfer
supernat
rather
highspe
centrifug
isotherm
amplificationbas
diagnost
blood
make
use
lamp
offer
highli
toler
mean
amplif
simpl
treatment
heat
chemic
increas
sensit
lamp
rtlamp
reaction
impress
exampl
direct
amplif
dna
blood
lampbas
technolog
isotherm
amplif
method
like
mda
assay
employ
postheat
centrifug
step
sinc
poon
et
al
demonstr
lamp
perform
directli
heattreat
blood
without
spindown
process
step
could
like
avoid
semidirect
process
even
though
success
exampl
simpl
direct
nucleic
acid
test
method
highlight
promis
dna
amplif
whole
blood
ongo
need
improv
assay
come
close
reach
capac
burckhardt
et
al
pcr
amplif
taq
polymeras
nearli
whole
blood
demonstr
year
ago
associ
treatment
method
one
technicallyinvolv
timeintens
demand
cycl
heat
cool
remain
seen
whether
isotherm
amplif
method
could
equal
toler
perhap
techniqu
make
decreas
level
toler
eas
use
evidenc
suzuki
et
al
achiev
incorpor
whole
blood
lamp
fiveminut
heat
dri
blood
spot
offer
conveni
altern
screen
genet
disord
test
infecti
diseas
profil
drug
metabol
set
limit
laboratori
storag
capabl
sampl
typic
prepar
spot
whole
blood
either
venou
blood
finger
prick
onto
filter
paper
sampl
time
quick
temperaturecontrol
storag
unnecessari
biohazard
risk
minim
health
care
worker
downsid
sampl
dna
dri
blood
must
elut
paperbas
cellular
compon
amplifi
filter
paper
use
medium
test
blood
infecti
diseas
sinc
syphili
diagnosi
world
war
ii
infant
screen
hiv
detect
monitor
modern
day
import
assay
dri
blood
spot
naat
commerci
technolog
even
becom
wide
avail
map
monitor
survey
blood
spot
patient
infect
malaria
neglect
tropic
diseas
similar
manner
prepar
process
techniqu
dri
blood
sampl
present
could
open
new
avenu
diseas
control
elimin
combin
wellstandard
assay
detect
bloodborn
pathogen
shown
figur
test
survey
valid
actual
dri
blood
spot
mostheavili
test
exampl
clinic
sampl
raskin
et
al
pretreat
heatingcool
cycl
addit
spermidin
reaction
help
boost
effici
yield
amplif
blood
spotcontain
filter
paper
typic
directli
ad
mixtur
reagent
though
necessit
overcom
high
background
interfer
filter
paper
detect
small
amount
dri
blood
overcom
background
interfer
filter
paper
directli
amplifi
dri
blood
spot
via
pcr
research
bolster
enzym
resist
inhibitor
includ
variou
buffer
compon
pretreat
fix
heat
also
aid
improv
sensit
specif
even
procedur
report
lengthi
poc
appropri
way
scale
wait
period
instanc
overnight
dri
period
methanol
vacuum
streamlin
fiveminut
methanol
fix
approach
amplifi
dna
directli
blood
spot
use
commerci
kit
inhous
buffer
water
overcom
variou
difficulti
imped
pcr
reaction
paper
matric
bufferbas
eluant
addit
costeffect
achiev
even
higher
sensit
standard
extract
protocol
similar
preparatori
approach
use
lamp
wherein
heat
water
phosphat
buffer
salin
pb
sodium
dodecyl
sulfat
sd
buffer
enabl
fast
easi
nucleic
acid
elut
amplif
result
compar
convent
gold
standard
microscopi
one
difficulti
make
blood
spot
suitabl
lamp
pcr
need
resuspend
spot
liquid
filter
speci
interest
easiest
way
address
former
problem
long
elut
time
latter
centrifug
make
taylor
et
al
amplif
plasmodium
spp
dna
directli
clinic
filter
paper
sampl
remark
achiev
lowresourc
set
combin
inhibitorresist
taq
mutant
enhanc
cocktail
result
specif
sensit
patient
sampl
approach
interest
characterist
make
special
none
achiev
eas
use
assay
malaria
blood
plasma
serum
wide
use
quantit
molecular
diagnost
area
clinic
decisionmak
therapeut
manag
plasma
pale
yellowish
fluid
normal
hold
blood
cell
whole
blood
suspens
wherea
serum
remnant
blood
plasma
remov
clot
factor
circul
dna
serum
plasma
biomark
divers
array
system
infecti
genet
diseas
includ
particular
disord
diabet
hepat
b
viru
refin
blood
serum
plasma
histor
requir
expens
equip
centrifug
sediment
recov
dna
rna
bloodbas
protein
nutrient
electrolyt
antibodi
particularli
igg
antigen
hormon
exogen
substanc
becom
even
challeng
consid
low
rel
level
cellfre
cellbound
nucleic
acid
recent
howev
paper
cardbas
devic
membranebas
sediment
microscal
devic
cell
differenti
filtrat
made
blood
separ
singl
step
process
poc
includ
sampl
type
assess
nucleic
acid
test
plasma
serum
see
reaction
perform
sampl
concentr
rang
figur
howev
import
note
sensit
necessarili
suffer
much
concentr
liu
et
al
highli
robust
twostep
amplif
process
direct
hairpin
assembl
hcrbase
detect
snp
dna
sequenc
vv
serum
achiev
low
lod
pg
plasmaserumbas
test
especi
promis
use
realworld
context
clinic
relev
case
examin
includ
test
patient
sampl
research
develop
conveni
pcr
assay
direct
semidirect
test
bloodbas
fluid
use
enhanc
enzym
dna
rna
target
success
amplifi
plasma
serum
addit
heatbas
pretreat
use
releas
nucleic
acid
prior
carri
amplif
effect
preheat
seen
lamp
well
lamp
gener
toler
serum
plasma
environ
preheat
input
sampl
found
favor
effect
produc
improv
sensit
heat
also
enabl
parde
et
al
detect
zika
viru
rna
serum
high
sensit
use
nasba
hcr
perform
especi
well
serum
without
pretreat
presum
reaction
reli
cascad
hybrid
event
instead
polymeras
plasma
serum
contain
lowabund
analyt
nucleic
acid
test
need
oper
high
sensit
fortun
lampbas
applic
achiev
increasingli
low
limit
detect
nijru
et
al
instanc
demonstr
lod
trypanozoan
parasitel
serum
hat
diagnosi
sensit
pcr
test
method
could
still
benefit
userfriendli
techniqu
largescal
process
semidirect
exampl
present
includ
centrifug
step
collect
condens
form
heat
could
easili
reli
pipett
collect
obviat
need
highspe
centrifug
other
might
benefit
certain
standalon
modul
plasma
serum
separ
could
integr
poc
workflow
saliva
sputum
abund
easi
obtain
thu
attract
sampl
diagnost
saliva
flow
oral
caviti
salivari
gland
blood
vessel
secret
protein
nucleic
acid
biomark
peripher
blood
contrast
bloodbas
sampl
saliva
sampl
requir
train
technician
present
fewer
antigenassoci
risk
easili
purifi
saliva
water
sputum
necessari
sampl
respiratori
infect
mucu
lower
airway
unfortun
saliva
sputum
heterogen
respect
distribut
organ
chemic
composit
presenc
outsid
contamin
toothpast
cigarett
smoke
coffe
mouthwash
technic
extract
kit
rnaqueou
magmax
life
technolog
grand
island
ny
usa
often
use
elimin
inhibitor
nucleas
oral
sampl
viscos
sputum
requir
particularli
cumbersom
protocol
sampl
prepar
full
process
begin
mucolyt
agent
nacetyllcystein
nalc
dithiothreitol
dtt
disrupt
mycobacteria
deterg
proteolyt
enzym
isol
target
dna
organ
solvent
captur
reagent
human
salivari
microbiom
import
diagnost
indic
oral
cancer
oral
diseas
periodont
system
diseas
pneumonia
sputum
becom
specimen
choic
detect
tuberculosi
naat
mycobacterium
tuberculosi
endors
world
health
organ
fda
high
accuraci
system
introduc
extend
practic
usag
sputum
poc
test
reduc
requir
sputum
manipul
report
nucleic
acid
test
method
saliva
sputum
show
fairli
high
number
patient
sampl
test
two
case
examin
clinic
specimen
figur
approach
examin
gener
employ
dilut
less
achiev
low
detect
limit
critic
avoid
fals
posit
target
concentr
sputum
saliva
small
lowest
lod
fg
acinetobact
baumannii
bacteri
gdna
pretreat
sputazym
kyokuto
tokyo
japan
heat
lamp
analysi
contrast
blood
high
water
content
saliva
make
rel
easi
augment
concentr
matrix
employ
amplif
reaction
sever
exampl
amplif
directli
dri
sputum
collect
via
filter
card
especi
promis
direct
direct
test
poc
sampl
need
store
handl
multipl
clinician
reevalu
later
date
amongst
collect
approach
direct
pcr
amplif
saliva
sampl
begin
dri
saliva
swab
fulli
circumv
dna
extract
purif
quantif
hall
et
al
ad
punch
saliva
stain
directli
reaction
mixtur
order
perform
str
analysi
genet
test
saliva
sputum
often
perform
directli
liquid
sampl
dilut
reagent
typic
suffici
negat
effect
inhibitor
although
heat
addit
polyethylen
glycol
peg
hydroxid
dithiothreitol
dtt
may
ad
process
sampl
broad
rang
bacteri
speci
present
mouth
inventori
differ
term
contribut
health
diseas
pcr
use
profil
larg
number
bacteria
speci
recalcitr
lyse
like
streptococcu
instead
reli
beadbeat
phenol
treatment
step
aa
et
al
appli
proteinas
k
lysat
directli
pcr
reagent
sever
group
follow
suit
detect
bacteri
taxa
healthi
diseas
saliva
sampl
direct
amplif
also
possibl
field
lampbas
diagnost
evidenc
test
zika
malaria
du
et
al
went
simplifi
sampl
treatment
tenminut
heat
zair
ebolaviru
dna
saliva
actual
provid
lamptoglucos
transduct
read
handheld
glucomet
design
direct
test
sputum
inher
difficult
mani
nucleic
acidbas
method
process
sampl
analog
culturebas
protocol
nacetyllcystein
nalc
naoh
method
viscou
sputum
matrix
liquefi
sever
buffer
exchang
highspe
centrifug
manipul
sampl
test
addit
concern
decontamin
necessari
cultur
also
use
protect
oper
biosafeti
hazard
molecular
test
sever
semidirect
exampl
base
lamp
recombinas
polymeras
amplif
rpa
pcr
adopt
practic
howev
sidebysid
comparison
nucleic
acid
test
sputum
sampl
without
naohnalc
treatment
indic
naohnalc
process
could
remov
enabl
truli
direct
protocol
sputum
mitarai
et
al
report
addit
nalc
sputum
specimen
prior
extract
effect
test
tb
furthermor
tarhan
et
al
show
sensit
tb
test
better
sputum
sampl
measur
directli
rather
extract
naohnalc
pursu
altern
lengthi
naohnalc
method
sputum
use
pcr
ad
mucolyt
agent
dilut
buffer
beadbeat
reduc
viscos
aggress
pretreat
reli
chemic
thermal
mechan
mean
disrupt
use
heat
centrifug
detect
tb
sputum
sampl
compar
perform
expens
molecularbas
system
one
particularli
noteworthi
exampl
direct
test
use
lamp
diagnos
tuberculosi
three
peripher
laboratori
studi
lamp
sensit
detect
smearneg
cultureposit
sputum
sampl
author
canvass
laboratori
personnel
implement
heat
wash
filtertip
captur
step
direct
amplif
verifi
assay
signific
potenti
adopt
routin
use
sever
earli
exampl
pcr
sputum
sampl
mycobacterium
spp
report
sensit
singledigit
copi
number
rang
howev
pretreat
method
quit
diverg
sjobr
et
al
use
long
centrifug
sonic
step
addit
boil
detect
eight
organ
sritharan
et
al
abl
cut
step
min
boil
period
result
lod
organ
sinc
exampl
one
techniqu
preamplif
wash
rpa
reaction
abl
match
perform
detect
singl
mycobacterium
far
combin
specif
sensit
without
ad
technic
difficulti
priy
et
al
recent
multiplex
rtlamp
detect
system
zika
dengu
chikungunya
achiev
lod
copiesreact
need
lysi
extract
impress
outcom
isotherm
technolog
like
rpa
lamp
illustr
fanci
hardwar
necessari
test
modal
achiev
high
specif
directli
human
sampl
swab
becom
mainstay
test
viral
pathogen
molecular
system
identifi
respiratori
tract
infect
nasal
swab
sti
sexual
transmit
infect
dermal
genit
conjunctiv
swab
use
rapid
accur
patient
diagnosi
dna
collect
swab
attract
simpl
minim
invas
even
enabl
selfsampl
howev
swabcollect
specimen
like
contain
polymeras
inhibitor
secret
miner
electrolyt
hormon
enzym
immunoglobulin
cytokin
well
topic
medic
result
mani
swab
test
market
remov
inhibitor
via
extract
method
involv
complex
suitabl
poc
swab
sampl
studi
examin
employ
least
one
patient
sampl
achiev
high
sensit
reason
level
dilut
buffer
use
dna
elut
solid
swab
figur
one
remark
studi
examin
patient
swab
direct
pcr
str
short
tandem
repeat
analysi
author
report
yield
dna
obtain
lowest
amount
detect
particularli
common
problem
amongst
lod
report
especi
difficult
replic
procedur
compar
manipul
use
sampl
storag
dna
replic
detect
special
attent
therefor
paid
reproduc
futur
effort
direct
amplif
swab
sampl
typic
elut
either
room
temperatur
heat
suffici
gener
pcramplifi
templat
swab
solut
method
dilut
heat
save
thirti
minut
process
time
nihonyanagi
et
al
heat
protocol
releas
mrsa
celleaseii
biocosm
inc
hyogo
japan
diluent
lampbas
test
swab
sampl
also
perform
roomtemperatur
heat
mda
particular
mahoni
et
al
lampbas
test
influenza
b
achiev
analyt
sensit
one
genom
equival
oper
via
novel
swab
prepar
procedur
vortex
heat
move
toward
instrumentfre
molecular
diagnost
system
lateralflow
stranddisplac
amplif
sda
assay
could
directli
detect
mrsa
nasal
swab
sensit
copiesreact
later
flow
elimin
need
expens
detector
rogdriguez
et
al
went
one
step
combin
paperbas
extract
situ
amplif
later
flow
develop
rtlamp
assay
patient
nasopharyng
specimen
sensit
copiesreact
well
mean
viral
load
patient
push
even
lower
limit
detect
hdabas
assay
verticalflow
dna
strip
readout
could
directli
test
clinic
genit
swab
transport
medium
hsv
type
nucleic
acid
assay
lod
copiesreact
respect
abl
detect
lowvir
load
sensit
cultur
test
sensit
test
swab
reli
lamp
reaction
exampl
fewer
copiesreact
viral
target
seen
brief
heat
step
hank
buffer
whittak
bioproduct
boston
usa
mswab
diluent
copan
diagnost
inc
murrieta
ca
usa
water
noteworthi
entir
swab
sampl
use
amplif
reaction
elimin
loss
start
materi
accompani
liquid
hardwar
transfer
approach
also
success
sever
instanc
str
test
rodriguez
et
al
use
similar
approach
detect
clinic
level
pass
inhous
elut
buffer
sampl
interest
filter
paperbas
setup
amplifi
filter
membran
futur
develop
could
focu
direct
reaction
swab
integr
extract
amplif
detect
singl
tube
poc
usag
would
give
lowresourc
set
altern
instrumentdepend
assay
like
aler
platform
detect
influenza
b
nasal
swab
diseas
kidney
genitourinari
tract
often
detect
stool
urin
urea
destabil
interact
primer
templat
polymeras
sinc
urea
typic
present
adult
urin
concentr
sixfold
greater
toler
pcr
reaction
ultracentrifug
relat
procedur
typic
use
prepar
sampl
nucleic
acid
test
molecular
test
identif
pathogen
stool
reli
extract
method
remov
proteinas
bile
salt
polyphenol
acid
directli
inhibit
activ
dna
polymeras
method
test
extern
specimen
integr
diagnost
screen
pathogen
chlamydia
trachomati
neisseria
gonorrhoea
clostridium
difficil
high
sensit
specif
survey
direct
nucleic
acid
test
method
figur
note
lod
gener
lower
urinebas
test
fecesbas
howev
one
exampl
direct
pcr
stool
sampl
take
advantag
buffer
addit
enhanc
phire
polymeras
new
england
biolab
ipswich
usa
achiev
lod
pg
bacteri
dna
howev
clear
need
increas
test
patient
sampl
nearli
half
referenc
work
includ
clinic
valid
issu
especi
notabl
fecal
test
patient
test
report
one
studi
though
complex
extract
method
recommend
prior
pcr
order
remov
inhibitori
compon
urin
fece
chang
reaction
chemistri
could
effect
reliev
neg
effect
sampl
matrix
urin
alter
take
form
hydrogelencas
reaction
author
develop
preassembl
desicc
gelbas
cassett
rehydr
liquid
raw
urin
sampl
polyacrylamid
gel
matrix
effect
filter
biolog
inhibitor
amplif
reaction
enabl
detect
mycoplasma
homoni
ureaplasma
urealyticum
fece
option
employ
inhibitorresist
polymeras
buffer
addit
case
one
largescal
character
hall
et
al
combin
phire
polymeras
new
england
biolab
ipswich
usa
ampdirect
biomatrica
san
diego
ca
gave
lod
nearli
one
copyreact
pcr
francisella
tularensi
stool
one
also
lyse
bacteria
urin
stool
heat
releas
amplifi
amount
target
dna
minim
level
inhibitor
moor
et
al
manag
detect
human
noroviru
repeatedli
outbreak
stool
sampl
boil
dilut
fece
pb
although
centrifug
employ
semidirect
method
creat
supernat
collect
stool
believ
dilut
step
could
accomplish
feat
allow
solid
settl
base
highli
aqueou
nonvisc
sampl
isotherm
amplif
techniqu
like
lamp
rpa
gener
demonstr
higher
toler
pcr
urin
carri
directli
lampbas
assay
without
preprocess
step
chemic
enhanc
detect
caus
agent
viral
infect
sti
pathogen
bacteria
escherichia
coli
develop
recent
establish
isotherm
method
siba
show
util
amplif
techniqu
detect
chlamydia
trachomati
neisseria
gonorrhoea
lowcopi
urin
sampl
landscap
molecular
diagnost
constantli
advanc
current
paradigm
healthcar
advent
mobil
health
telemedicin
decentr
patient
care
also
put
new
emphasi
usabl
noninvas
diseas
test
nucleic
acid
diagnost
reduc
difficulti
expenditur
standard
multistep
procedur
direct
amplif
expedit
patient
test
poc
hospit
laboratori
situat
review
thu
motiv
discuss
current
state
art
direct
naat
assay
platform
requir
minim
sampl
prepar
procedur
search
literatur
find
publish
work
consid
direct
naat
first
categor
work
base
type
complex
sampl
subsequ
employ
bubbl
plot
facilit
comparison
amplif
method
robust
complex
media
sensit
target
clinic
usag
find
indic
major
direct
naat
exhibit
toler
less
sampl
interest
fewer
patientbas
evalu
still
diagnost
procedur
far
surpass
averag
sim
et
al
studi
direct
pcr
buccal
swab
instanc
robust
carri
directli
entir
sampl
maxim
eas
improv
must
continu
made
sampl
type
term
facilit
level
evalu
clinic
sampl
despit
signific
develop
date
remain
sever
challeng
realiz
direct
naat
userfriendli
consist
generaliz
further
develop
direct
test
import
take
holist
approach
consid
type
sampl
analyz
method
sampl
acquisit
throughput
volum
chemic
mechan
requir
amplif
techniqu
anoth
key
point
note
differ
matric
function
best
differ
environ
improv
understand
mechan
behind
emerg
nucleic
acid
amplif
reaction
mutant
polymeras
enabl
ration
inhibitori
compound
make
break
amplif
system
furthermor
molecular
assay
much
learn
diagnost
continu
develop
commerci
pipelin
proprietari
technolog
alway
hold
knowledg
cost
user
implement
new
idea
lead
research
toward
better
success
way
modern
everchang
field
diseas
test
enter
age
electron
mobil
person
medicin
remain
much
room
creativ
innov
design
naat
poc
diagnost
molecular
diagnost
highestgrow
segment
vitro
diagnost
product
truli
great
potenti
develop
lowresourc
area
diagnost
commun
continu
strive
test
reliabl
variabl
electr
resourc
water
qualiti
train
staff
harsh
environment
condit
research
continu
seek
approv
fda
clia
waiver
assur
afford
sensit
specif
userfriendli
rapid
robust
equipmentfre
deliv
endus
criteria
regard
direct
naat
present
promis
approach
review
hope
stimul
discuss
direct
naat
potenti
poc
diagnost
ultim
seek
help
acceler
develop
poc
diagnost
clia
waiv
andor
meet
assur
criteria
therebi
usher
next
revolut
healthcar
